Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...

Pfizer PFE has committed significant resources for the development of treatments in the fields of oncology, internal medicine ...

On Friday, June 27, the American Lung Association honored Pfizer with the Outstanding Corporate Partner Award at its annual awards celebration in Chicago for their long-standing commitment, leadership ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ...

The endometriosis market is expected to grow from $938.0m in 2024 to $2.5 billion in 2034, at a compound annual growth rate ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...